Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylation

This publication has 14 references indexed in Scilit:

• Bufuralol metabolism in human liver: a sensitive probe for the debrisoquine‐type polymorphism of drug oxidation
  European Journal of Clinical Investigation, 1984
• Assessment of the drug metabolism capacity of the liver.
  British Journal of Clinical Pharmacology, 1982
• The genetic controlof bufuralol metabolisminman
  European Journal of Drug Metabolism and Pharmacokinetics, 1982
• The Upjohn Award Lecture 1981/La Conférence Upjohn 1981: The metabolism of xenobiotics in different populations
  Canadian Journal of Physiology and Pharmacology, 1982
• Defective Oxidation of Drugs
  Clinical Pharmacokinetics, 1982
• Clinical pharmacology. Possible clinical importance of genetic differences in drug metabolism.
  BMJ, 1981
• Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.
  Published by Wiley ,1981
• A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.
  Journal of Medical Genetics, 1980
• Defective N-oxidation of sparteine in man: A new pharmacogenetic defect
  European Journal of Clinical Pharmacology, 1979
• POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
  The Lancet, 1977